Richard Hartnell – Psychedelic Science (MAPS) 2017 Interview

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">



Please visit us for inspiration, ideas, information, and LOVE!
http://soulDocumentary.love

S.O.U.L. endeavors to further expand consciousness by sharing our experience from the MAPS sponsored Psychedelic Science 2017 conference, where the international scientific community came together at the Oakland Marriott City Center to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical cannabis, and more for such applications as: psychotherapy, neuroscience, spirituality, creativity, ...

Continue Reading →

Don Lattin – Psychedelic Science (MAPS) 2017 Interview

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">



Please visit us for inspiration, ideas, information, and LOVE!
http://soulDocumentary.love

S.O.U.L. endeavors to further expand consciousness by sharing our experience from the MAPS sponsored Psychedelic Science 2017 conference, where the international scientific community came together at the Oakland Marriott City Center to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical cannabis, and more for such applications as: psychotherapy, neuroscience, spirituality, creativity, ...

Continue Reading →

Mike Crowley – Psychedelic Science (MAPS) 2017 Interview

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">



Please visit us for inspiration, ideas, information, and LOVE!
http://soulDocumentary.love

S.O.U.L. endeavors to further expand consciousness by sharing our experience from the MAPS sponsored Psychedelic Science 2017 conference, where the international scientific community came together at the Oakland Marriott City Center to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical cannabis, and more for such applications as: psychotherapy, neuroscience, spirituality, creativity, ...

Continue Reading →

Arizona Psychedelics Conference

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">



This is the first ever Psychedelics Conference in Arizona. “This three-day event seeks to examine the therapeutic potential of psychedelics like psilocybin, ayahuasca, peyote, MDMA, DMT, ibogaine, ketamine, cannabis, and more. Join us to examine the role of psychedelic drugs and plant medicines in science, medicine, culture, and spirituality.” Conference description courtesy of Arizona Psychedelics Conference. Speakers, exhibitors, workshops & vendors came from all over the us/world ...

Continue Reading →

ESPD50: Ken Alper – The Ibogaine Project: Urban ethnomedicine for opioid use disorder

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">

Kenneth Alper, M.D. is an Associate Professor of Psychiatry and Neurology at the New York University School of Medicine. Dr. Alper has studied ibogaine from the perspective medical ethnography, working with Howard Lotsof, the originator of the use of ibogaine in the treatment of substance use disorders, accessing the geographically and clinically diverse “medical subculture” to yield systematic observation on ibogaine in heroin detoxification, and quantitative and ...

Continue Reading →
Page 1 of 20 12345...»
SSL Certificates
UA-77446339-1